SEC Filings | Jasper Therapeutics, Inc

Filing date	Description	Form	Filing Group	View
October 13, 2022	EFFECT	EFFECT	Other	9999999995-22-003029.pdf 9999999995-22-003029.rtf 9999999995-22-003029.xls View HTML
October 18, 2022	EFFECT	EFFECT	Other	9999999995-22-003076.pdf 9999999995-22-003076.rtf 9999999995-22-003076.xls View HTML
May 5, 2023	EFFECT	EFFECT	Other	9999999995-23-001326.pdf 9999999995-23-001326.rtf 9999999995-23-001326.xls View HTML
May 18, 2021	Notification that form type 10-Q will be submitted late	NT 10-Q	Quarterly Filings	0001213900-21-027633.pdf 0001213900-21-027633.rtf 0001213900-21-027633.xls View HTML
March 24, 2022	Post-effective amendment to an S-Type filing	POS AM	Registration Statements	0001213900-22-014845.pdf 0001213900-22-014845.rtf 0001213900-22-014845.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
October 7, 2022	Post-effective amendment to an S-Type filing	POS AM	Registration Statements	0001213900-22-062795.pdf 0001213900-22-062795.rtf 0001213900-22-062795.xls View HTML
April 10, 2023	A preliminary proxy statement providing notification matters to be brought to a vote	PRE 14A	Proxy Filings	0001213900-23-028579.pdf 0001213900-23-028579.rtf 0001213900-23-028579.xls View HTML
November 9, 2023	A preliminary proxy statement providing notification matters to be brought to a vote	PRE 14A	Proxy Filings	0001213900-23-085198.pdf 0001213900-23-085198.rtf 0001213900-23-085198.xls View HTML
October 25, 2019	Registration statement for face-amount certificate companies	S-1	Registration Statements	0001213900-19-021144.pdf 0001213900-19-021144.rtf 0001213900-19-021144.xls View HTML
October 18, 2021	Registration statement for face-amount certificate companies	S-1	Registration Statements	0001213900-21-053099.pdf 0001213900-21-053099.rtf 0001213900-21-053099.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.